Mixed amphetamine salts: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) No edit summary |
Pharmacopedia: approved experience contribution |
||
| Line 73: | Line 73: | ||
* <effect ref="withdrawal" author="MDElliottMD">Low motivation, low mood, hypersomnia, increased appetite on abrupt discontinuation.</effect> | * <effect ref="withdrawal" author="MDElliottMD">Low motivation, low mood, hypersomnia, increased appetite on abrupt discontinuation.</effect> | ||
* <effect ref="urinary-retention" author="MDElliottMD">Difficult/slow urination</effect> | * <effect ref="urinary-retention" author="MDElliottMD">Difficult/slow urination</effect> | ||
<effect ref="focus-intensification"/> | |||
<effect ref="appetite-suppression"/> | |||
<effect ref="alertness"/> | |||
<effect ref="executive-functioning"/> | |||
| pk_absorption = Excellent oral bioavailability — sources report ">75%" to "~90%". Food does not significantly affect total absorption but can delay peak concentration. | | pk_absorption = Excellent oral bioavailability — sources report ">75%" to "~90%". Food does not significantly affect total absorption but can delay peak concentration. | ||
| pk_distribution = Volume of distribution ~4 L/kg; plasma protein binding less than 20%. Crosses the blood–brain barrier and placenta. | | pk_distribution = Volume of distribution ~4 L/kg; plasma protein binding less than 20%. Crosses the blood–brain barrier and placenta. | ||